Mylan is a global healthcare company focused on making high quality medicines available to everyone who needs them. We offer a robust portfolio of more than 7,500 products, including biosimilars, generics, brand and over-the-counter remedies.
To learn more about our portfolio in the United States, click here. To learn more about our portfolio in other countries, please visit our country pages.
We’re also one of the world’s largest manufacturers of active pharmaceutical ingredients (API). APIs are the part of pharmaceuticals that produce the medication’s intended effect.
Mylan markets products in more than 165 countries and territories. Our customers include consumers, retail and pharmacy establishments, wholesalers, governments, institutions and physicians.
Over the past few years, Mylan has focused its product portfolio in 10 major therapeutic areas (see below). We have critical mass in these areas, though our sales emphasis varies by market according to opportunity. This categorization of therapeutic franchises also helps us better focus on patient needs by providing prescription generics, branded generics, brand-name drugs and OTC remedies where they are needed most. This structure helps us look at healthcare holistically, and it challenges us to provide access throughout the course of patient lives.